Cumberland Pharmaceuticals, Inc. (CPIX): Are Hedge Funds Right About This Stock?
A whopping number of 13F filings filed with U.S.
Cumberland Pharmaceuticals Inc (CPIX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 622,228 | $1,291 | -4% | 0% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 34,592 | $72 | -67% | 0% |
| 3. | 32,300 | $67 | +128% | 0% | |
| 4. | Millennium Management Israel Englander | 10,835 | $22 | -24% | 0% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.45 | 20 | Director | 17,682 | 2022-08-15 | Filing | |
| $2.52 | 26 | Director | 17,662 | 2022-08-12 | Filing | |
| $2.46 | 26 | Director | 17,636 | 2022-08-11 | Filing | |
| $2.19 | 26 | Director | 17,610 | 2022-08-10 | Filing | |
| $2.19 | 26 | Director | 17,584 | 2022-08-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.79 | 1,000 | Director | 0 | 2019-12-04 | Filing | |
| $5.31 | 3,470 | Director | 1,000 | 2019-09-25 | Filing | |
| $5.27 | 4,400 | Director | 4,470 | 2019-09-23 | Filing | |
| $5.31 | 3,700 | Director | 8,870 | 2019-09-20 | Filing | |
| $5.21 | 4,000 | Director | 12,170 | 2019-09-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 627,200 | $1,302 | 0% | |
| 2. | 374,691 | $778 | 0% | |
| 3. | 286,655 | $595 | 0.01% | |
| 4. | 189,048 | $392 | 0.02% | |
| 5. | 188,164 | $390 | 0% |
News See All
Where Do Hedge Funds Stand On Cumberland Pharmaceuticals, Inc. (CPIX)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Is Cumberland Pharmaceuticals (CPIX) A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Cumberland Pharmaceuticals, Inc. (CPIX): Hedge Funds In Wait-and-See Mode
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
13G Filing: Ariel Investments and Cumberland Pharmaceuticals Inc (CPIX)
You can access the original SEC filing by clicking here.
Cumberland Pharmaceuticals Inc (CPIX): Ariel Investments Snapping Up Shares
Ariel Investments disclosed a large increase in its stake in Cumberland Pharmaceuticals Inc (CPIX) today.
Is Cumberland Pharmaceuticals, Inc. (CPIX) A Good Stock To Buy?
The market has been volatile as the Federal Reserve winds down its easy money policies.
John Rogers, Ariel Also Disclose a 10.9% Stake in Cumberland Pharmaceuticals
In a new 13G filing just reported to the SEC, John W. Rogers' Ariel Investments has disclosed a 10.9% stake in Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX).
Alexza Pharmaceuticals, Inc. (ALXA): Watch This Important Indicator
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) was in 2 hedge funds' portfolio at the end of December.
Billionaire Hedge Funds
